Microsoft Word[removed]Novozymes Biopharma EpiVax PR.docx

First Page		Document Content
Date: 2013-02-12 04:42:24 Novozymes Immunogenicity Autoimmunity Bagsværd Immune system Immunotherapy Monoclonal antibodies Vaccine Immunology Medicine Biology		Microsoft Word[removed]Novozymes Biopharma EpiVax PR.docx Add to Reading List Source URL: www.biopharma.novozymes.com Download Document from Source Website File Size: 141,37 KB Share Document on Facebook

	Universal detection reagent for immunogenicity assays EBF – Young Scientist Symposium 2015 Elli Oksanen DocID: 1v3Ky - View Document
	Induction of Tolerance to Immunotoxins Using Nanoparticle Delivery of Rapamycin Ronit Mazor and Ira Pastan Immunogenicity summit October 2016 DocID: 1uGDJ - View Document
	The UNM Interdisciplinary HPV Prevention Center DocID: 1rtWC - View Document
	Overview ActoBiotics® Platform: A Novel Class of Oral Biotherapeutics DocID: 1rtnN - View Document
	ABIRISK ABIRISK Project Officially Started A growing number of medicines are based on biological molecules such as proteins and monoclonal antibodies. These novel drugs have resulted in new, more effective treatments for DocID: 1rlyu - View Document